Method Development and Validation of Ephedrine and Pseudoephedrine in Horse Urine by Liquid Chromatography-Tandem Mass Spectrometry

ABSTRACT

Background: A comprehensive, fast and precise method for the quantification of ephedrine and pseudoephedrine in horse urine was established and validated utilizing Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) followed by the necessities of Association of Official Racing Chemists (AORC), Federation of Equine International (FEI) and International Council for Harmonization (ICH) guidelines. Methodology: The processing of samples was performed by de conjugation accompanied by enzymatic hydrolysis, Solid Phase Extraction (SPE) procedure using HLB cartridges. Results: The total chromatographic run time of this method was 7.0 min and found linear over the concentration range of 4-40 ng/mL with a correlation of coefficient (r2) of 0.99. The intraday and inter-day assay precision of ephedrine were extended from 1.64 to 2.86% and 1.61 to 3.12 %, respectively. In context of pseudoephedrine, the intraday and interday assay precision were ranged from 1.55 to 3.26% and 1.11 to 2.60 %, respectively. The absolute percent recovery (%) was found to be 85% for Ephedrine and 90% for Pseudoephedrine. The percent recovery was adequate to discriminate and quantitate the Ephedrine and Pseudoephedrine at or below the level prescribed by AORC Proficiency Testing (PT) list ie 20ng/ ml for equine urine sample. The LOD and LOQ were found 2 and 4 ng/ml respectively for Ephedrine and Pseudoephedrine. Conclusion: A comprehensive and precise method for quantitative estimation and diastereomeric differentiation of Ephedrine and Pseudoephedrine by LC-MS/MS was well established and validated according to AORC, FEI and ICH guidelines. This strategy may be additionally utilized for remedial medication checking purposes.

KEYWORDS

• Ephedrine
• Pseudoephedrine
• ICH Guidelines
• Doping control
• Mass
• spectrometry
• AORC
• Validation

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.54.3s.167Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 54, ISSUE 3SRational Design and Characterization of Transdermal Patch of Irbesartan for HypertensionRoshan Kumar Dubey, Hitesh Kumar Dewangan · pp. s464–s472Original ArticleSame type: Article
• Article · VOLUME 54, ISSUE 3SSolid Dosage Forms: A Detailed Research on Non-conforming Product QualityKatta Hemanth G, Ravindra Shenoy U, Girish Thunga, Sudeep Kumar Agrawal, Mahendra Joshi, Muddukrishna Badamane Sathyanarayana, Vamshi Krishna Tippavajhala, Abhinaya N, Girish Pai Kulyadi · pp. s473–s484Original ArticleSame type: Article
• Article · VOLUME 54, ISSUE 3SEffect of Plasticizer on Delivery of Valsartan from Tamarind Gel Based Transdermal Film FormulationBraja Bihari Panda, Ayan Chatterjee, Rudra Narayan Sahoo, Subrata Mallick · pp. s485–s491Original ArticleSame type: Article
• Article · VOLUME 54, ISSUE 3SEffective Single Drug Treatment of Lymphatic Filariasis through Enhanced Transdermal Delivery of Ivermectin Liposomes using Solid and Dissolving MicroneedlesJyothirmayee Devineni, Ch.Durga Pravallika, Boothapati Sudha Rani, Buchi Naidu Nalluri · pp. s492–s504Original ArticleSame type: Article